BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26011160)

  • 1. Xanthohumol inhibits Notch signaling and induces apoptosis in hepatocellular carcinoma.
    Kunnimalaiyaan S; Sokolowski KM; Balamurugan M; Gamblin TC; Kunnimalaiyaan M
    PLoS One; 2015; 10(5):e0127464. PubMed ID: 26011160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.
    Kunnimalaiyaan S; Trevino J; Tsai S; Gamblin TC; Kunnimalaiyaan M
    Mol Cancer Ther; 2015 Jun; 14(6):1395-403. PubMed ID: 25887885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines.
    Engelsgjerd S; Kunnimalaiyaan S; Kandil E; Gamblin TC; Kunnimalaiyaan M
    PLoS One; 2019; 14(3):e0213776. PubMed ID: 30870485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells.
    Dorn C; Weiss TS; Heilmann J; Hellerbrand C
    Int J Oncol; 2010 Feb; 36(2):435-41. PubMed ID: 20043079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells.
    Zhang S; Yang Y; Liang Z; Duan W; Yang J; Yan J; Wang N; Feng W; Ding M; Nie Y; Jin Z
    PLoS One; 2013; 8(12):e83699. PubMed ID: 24386256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthohumol exhibits anti-myeloma activity in vitro through inhibition of cell proliferation, induction of apoptosis via the ERK and JNK-dependent mechanism, and suppression of sIL-6R and VEGF production.
    Sławińska-Brych A; Zdzisińska B; Czerwonka A; Mizerska-Kowalska M; Dmoszyńska-Graniczka M; Stepulak A; Gagoś M
    Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129408. PubMed ID: 31386885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death.
    Chen PH; Chang CK; Shih CM; Cheng CH; Lin CW; Lee CC; Liu AJ; Ho KH; Chen KC
    Neuropharmacology; 2016 Nov; 110(Pt A):362-375. PubMed ID: 27487563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative and Cytotoxic Activity of Xanthohumol and Its Non-Estrogenic Derivatives in Colon and Hepatocellular Carcinoma Cell Lines.
    Logan IE; Miranda CL; Lowry MB; Maier CS; Stevens JF; Gombart AF
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanthohumol induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI3K/Akt/mTOR-kinase in human gastric cancer cells.
    Guo D; Zhang B; Liu S; Jin M
    Biomed Pharmacother; 2018 Oct; 106():1300-1306. PubMed ID: 30119200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suberoylanilide hydroxamic Acid, a histone deacetylase inhibitor, alters multiple signaling pathways in hepatocellular carcinoma cell lines.
    Kunnimalaiyaan S; Sokolowski K; Gamblin TC; Kunnimalaiyaan M
    Am J Surg; 2017 Apr; 213(4):645-651. PubMed ID: 28007318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro.
    Wei S; Sun T; Du J; Zhang B; Xiang D; Li W
    Oncol Rep; 2018 Dec; 40(6):3213-3222. PubMed ID: 30272303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced effects of xanthohumol plus honokiol on apoptosis in 3T3-L1 adipocytes.
    Yang JY; Della-Fera MA; Rayalam S; Baile CA
    Obesity (Silver Spring); 2008 Jun; 16(6):1232-8. PubMed ID: 18369342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthohumol inhibits cell proliferation and induces apoptosis in human thyroid cells.
    Carvalho DO; Freitas J; Nogueira P; Henriques SN; Carmo AM; Castro MA; Guido LF
    Food Chem Toxicol; 2018 Nov; 121():450-457. PubMed ID: 30240731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma.
    Walden D; Kunnimalaiyaan S; Sokolowski K; Clark TG; Kunnimalaiyaan M
    Oncotarget; 2017 Oct; 8(50):88069-88078. PubMed ID: 29152142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro.
    Sławińska-Brych A; Król SK; Dmoszyńska-Graniczka M; Zdzisińska B; Stepulak A; Gagoś M
    Chem Biol Interact; 2015 Oct; 240():110-8. PubMed ID: 26297991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model.
    Zhang W; Pan Y; Gou P; Zhou C; Ma L; Liu Q; Du Y; Yang J; Wang Q
    Oncol Rep; 2018 Jan; 39(1):280-288. PubMed ID: 29138867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells.
    Chiang IT; Chen WT; Tseng CW; Chen YC; Kuo YC; Chen BJ; Weng MC; Lin HJ; Wang WS
    Anticancer Res; 2017 Jan; 37(1):161-167. PubMed ID: 28011486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells.
    Deeb D; Gao X; Jiang H; Arbab AS; Dulchavsky SA; Gautam SC
    Anticancer Res; 2010 Sep; 30(9):3333-9. PubMed ID: 20944105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells.
    Sławińska-Brych A; Zdzisińska B; Dmoszyńska-Graniczka M; Jeleniewicz W; Kurzepa J; Gagoś M; Stepulak A
    Toxicology; 2016 May; 357-358():65-73. PubMed ID: 27317025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells.
    Dokduang H; Yongvanit P; Namwat N; Pairojkul C; Sangkhamanon S; Yageta MS; Murakami Y; Loilome W
    Oncol Rep; 2016 Apr; 35(4):2065-72. PubMed ID: 26794001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.